Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
Abstract Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease that often requires biological therapy to control its activity. Medication persistence and adherence are important aspects on which we have scarce information. We performed a longitudinal, retrospective, and observational...
Guardado en:
Autores principales: | Juan Carlos Nieto-González, Laura Trives-Folguera, Alejandra Melgarejo-Ortuño, Aranzazu Ais, Belén Serrano-Benavente, María Sanjurjo, José María Álvaro-Gracia, Indalecio Monteagudo Sáez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d8239bb0ae3444ea771d572512aa78a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MRI Findings in Hip in Juvenile Idiopathic Arthritis
por: Monika Ostrowska, et al.
Publicado: (2021) -
Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Jasmin B Kuemmerle-Deschner, et al.
Publicado: (2009) -
Review of environmental factors and juvenile idiopathic arthritis
por: Horton DB, et al.
Publicado: (2019) -
Challenges in the management of juvenile idiopathic arthritis with etanercept
por: Clare E Pain, et al.
Publicado: (2009) -
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami M, et al.
Publicado: (2012)